, Volume 20, Issue 6, pp 413-416

Reduction of menopausal hot flushes by methyldopa

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


In a double-blind study, methyldopa was shown to be significantly more effective than placebo in reducing menopausal hot flushes. The median reduction in the number of hot flushes was 38% with placebo and 65% with methyldopa. The active metabolite of methyldopa, alpha-methylnoradrenaline, is an alpha2-adrenoceptor agonist. Since the alpha2-adrenoceptor agonist clonidine also reduces hot flushes, while the alpha2-adrenoceptor antagonist yohimbine produces flushes, it is speculated that menopausal hot flushes might result from a reduced stimulation of alpha2-adrenoceptors, probably in the CNS.